Preferential Gs protein coupling of the galanin Gal

Analgesics, Opioid / pharmacology Galanin Mesencephalon Peptides Receptors, Opioid
DAMGO (PubChem CID: 5462471) Endomorphin-1 (PubChem CID: 5311080) Fentanyl (PubChem CID: 3345) G protein coupled receptor oligomerization Galanin (PubChem CID: 16133823) Galanin receptors M40 (PubChem CID: 16133821) M617 (PubChem CID: 16158157) Methadone (PubChem CID: 4095) Naloxone (PubChem CID: 5284596) Opioid receptors Total internal reflection fluorescence microscopy

Journal

Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422

Informations de publication

Date de publication:
08 2022
Historique:
received: 07 04 2022
revised: 18 06 2022
accepted: 19 06 2022
pubmed: 25 6 2022
medline: 10 8 2022
entrez: 24 6 2022
Statut: ppublish

Résumé

Recent studies have proposed that heteromers of µ-opioid receptors (MORs) and galanin Gal

Identifiants

DOI: 10.1016/j.phrs.2022.106322 PMID: 35750299 PMC: PMC9462584
pubmed: 35750299
pii: S1043-6618(22)00267-5
doi: 10.1016/j.phrs.2022.106322
pmc: PMC9462584
mid: NIHMS1832290
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Peptides 0
Receptors, Opioid 0
Galanin 88813-36-9

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106322

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA049257
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL144615
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA DA000493
Pays : United States

Informations de copyright

Published by Elsevier Ltd.

Références

J Neurosci. 1998 May 15;18(10):3489-500
pubmed: 9570780
Nat Commun. 2022 Mar 15;13(1):1364
pubmed: 35292680
Nature. 2012 Mar 21;485(7398):321-6
pubmed: 22437502
Nat Methods. 2007 Apr;4(4):319-21
pubmed: 17369835
Brain Res. 1993 Jan 15;600(2):268-72
pubmed: 7679604
PLoS Biol. 2015 Jul 09;13(7):e1002194
pubmed: 26158621
Cell Mol Life Sci. 2021 Apr;78(8):3957-3968
pubmed: 33580270
Nat Methods. 2021 Apr;18(4):397-405
pubmed: 33686301
J Pharmacol Exp Ther. 2004 Feb;308(2):574-82
pubmed: 14610237
Pharmacol Rev. 2014 Feb 10;66(2):413-34
pubmed: 24515647
Pharmacol Rev. 2015;67(1):118-75
pubmed: 25428932
J Gen Physiol. 2011 May;137(5):441-54
pubmed: 21518833
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3609-18
pubmed: 26100888
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6686-E6694
pubmed: 28743749
BMC Biol. 2020 Jan 23;18(1):9
pubmed: 31973708
Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):E1438-46
pubmed: 24591645
Biochemistry. 2013 Oct 22;52(42):7405-27
pubmed: 24047497
Nat Struct Mol Biol. 2006 Sep;13(9):778-86
pubmed: 16906158
Mol Pharmacol. 2014 Oct;86(4):417-29
pubmed: 25097189
Pharmacol Ther. 2022 Mar;231:107977
pubmed: 34480967
J Neurosci. 2017 Feb 1;37(5):1176-1186
pubmed: 28007761
Annu Rev Biochem. 2021 Jun 20;90:739-761
pubmed: 33756098
Annu Rev Biophys Biomol Struct. 2000;29:291-325
pubmed: 10940251
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11287-91
pubmed: 7504301
J Pharmacol Exp Ther. 1998 Nov;287(2):448-56
pubmed: 9808667
Pharmacol Rev. 2013 Jan 15;65(1):223-54
pubmed: 23321159
Mol Pharmacol. 2005 Jun;67(6):2173-84
pubmed: 15778451
Curr Opin Pharmacol. 2017 Feb;32:23-31
pubmed: 27835800
Trends Pharmacol Sci. 2018 Jul;39(7):672-684
pubmed: 29739625
J Gen Physiol. 2013 Jun;141(6):737-46
pubmed: 23712552
Nat Commun. 2018 Mar 28;9(1):1242
pubmed: 29593213
Science. 1999 Sep 3;285(5433):1569-72
pubmed: 10477521
Pharmacol Res. 2019 Jan;139:337-347
pubmed: 30472462
Trends Pharmacol Sci. 2015 Mar;36(3):145-52
pubmed: 25704194
Front Plant Sci. 2013 Oct 29;4:413
pubmed: 24194740
J Neurosci. 1998 Dec 1;18(23):10070-7
pubmed: 9822761
Nat Struct Mol Biol. 2013 Apr;20(4):419-25
pubmed: 23435379
Biochemistry. 2011 Apr 12;50(14):2829-37
pubmed: 21361347
Nucleic Acids Res. 2022 Jan 7;50(D1):D518-D525
pubmed: 34570219
Annu Rev Pharmacol Toxicol. 2016;56:403-25
pubmed: 26514203
Neuropeptides. 2005 Dec;39(6):535-46
pubmed: 16242774
Pharmacol Res. 2021 Aug;170:105745
pubmed: 34182128
Nat Chem Biol. 2011 Jul 24;7(9):624-30
pubmed: 21785426
Science. 2019 Apr 26;364(6438):389-394
pubmed: 31023924
Nature. 2006 Sep 21;443(7109):355-8
pubmed: 16971952
Nature. 2018 Jun;558(7711):547-552
pubmed: 29899455
J Clin Invest. 2019 Mar 26;129(7):2730-2744
pubmed: 30913037
Neuron. 2011 Jan 13;69(1):120-31
pubmed: 21220103
Front Endocrinol (Lausanne). 2012 Oct 26;3:127
pubmed: 23112793
Ann N Y Acad Sci. 1998 Dec 21;863:156-69
pubmed: 9928168
Prog Mol Biol Transl Sci. 2020;169:297-321
pubmed: 31952690
Sci Rep. 2018 May 16;8(1):7705
pubmed: 29769636
Nat Chem Biol. 2021 Dec;17(12):1238-1244
pubmed: 34556862
Pharmacol Ther. 2009 Nov;124(2):248-57
pubmed: 19664655
BMC Biol. 2018 Feb 28;16(1):24
pubmed: 29486745
J Biol Chem. 2014 Aug 29;289(35):24347-65
pubmed: 25023280
Pharmacol Ther. 2007 Dec;116(3):343-54
pubmed: 17935788
Nat Chem Biol. 2020 Sep;16(9):946-954
pubmed: 32541966

Auteurs

Paulo A De Oliveira (PA)

Integrative Neurobiology Section, USA.

Estefanía Moreno (E)

Laboratory of Molecular Neuropharmacology, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology and Institute of Biomedicine, University of Barcelona, Barcelona, Spain.

Nil Casajuana-Martin (N)

Laboratory of Computational Medicine, Biostatistics Unit, Faculty of Medicine, Autonomous University of Barcelona, Bellaterra, Spain.

Verònica Casadó-Anguera (V)

Laboratory of Molecular Neuropharmacology, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology and Institute of Biomedicine, University of Barcelona, Barcelona, Spain.

Ning-Sheng Cai (NS)

Integrative Neurobiology Section, USA.

Gisela Andrea Camacho-Hernandez (GA)

Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.

Hu Zhu (H)

Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.

Alessandro Bonifazi (A)

Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.

Matthew D Hall (MD)

Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.

David Weinshenker (D)

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.

Amy Hauck Newman (AH)

Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.

Diomedes E Logothetis (DE)

Departments of Pharmaceutical Sciences, Chemistry and Chemical Biology and Center for Drug Discovery, School of Pharmacy at the Bouvé College of Health Sciences and College of Science, Northeastern University, Boston, MA, USA.

Vicent Casadó (V)

Laboratory of Molecular Neuropharmacology, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology and Institute of Biomedicine, University of Barcelona, Barcelona, Spain. Electronic address: vcasado@ub.edu.

Leigh D Plant (LD)

Departments of Pharmaceutical Sciences, Chemistry and Chemical Biology and Center for Drug Discovery, School of Pharmacy at the Bouvé College of Health Sciences and College of Science, Northeastern University, Boston, MA, USA. Electronic address: l.plant@northeastern.edu.

Leonardo Pardo (L)

Laboratory of Computational Medicine, Biostatistics Unit, Faculty of Medicine, Autonomous University of Barcelona, Bellaterra, Spain. Electronic address: Leonardo.Pardo@uab.cat.

Sergi Ferré (S)

Integrative Neurobiology Section, USA. Electronic address: sferre@intra.nida.nih.gov.

Articles similaires

Proteomimetic polymer blocks mitochondrial damage, rescues Huntington's neurons, and slows onset of neuropathology in vivo.

Wonmin Choi, Mara Fattah, Yutong Shang et al.
1.00
Animals Huntington Disease Mitochondria Neurons Mice

Effects of oxycodone on placental lineages: Evidence from the transcriptome profile of mouse trophoblast giant cells.

Zhen Lyu, Jessica A Kinkade, Nathan J Bivens et al.
1.00
Animals Trophoblasts Female Pregnancy Oxycodone

PRR adjuvants restrain high stability peptides presentation on APCs.

Bin Li, Jin Zhang, Taojun He et al.
1.00
Animals Adjuvants, Immunologic Mice Antigen-Presenting Cells Antigen Presentation

Encoding extracellular modification of artificial cell membranes using engineered self-translocating proteins.

Alexander Harjung, Alessandro Fracassi, Neal K Devaraj
1.00
Hemolysin Proteins Artificial Cells Protein Engineering Protein Transport Cell Membrane

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Dépresseurs du système nerveux central › Stupéfiants › Analgésiques morphiniques › Preferential Gs protein coupling of the galanin Gal
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines de tissu nerveux › Neuropeptides › Galanine › Preferential Gs protein coupling of the galanin Gal
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Tronc cérébral › Mésencéphale › Preferential Gs protein coupling of the galanin Gal
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Preferential Gs protein coupling of the galanin Gal
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur aux neuropeptides › Récepteurs aux opioïdes › Preferential Gs protein coupling of the galanin Gal